JP2017523810A5 - - Google Patents

Download PDF

Info

Publication number
JP2017523810A5
JP2017523810A5 JP2017526770A JP2017526770A JP2017523810A5 JP 2017523810 A5 JP2017523810 A5 JP 2017523810A5 JP 2017526770 A JP2017526770 A JP 2017526770A JP 2017526770 A JP2017526770 A JP 2017526770A JP 2017523810 A5 JP2017523810 A5 JP 2017523810A5
Authority
JP
Japan
Prior art keywords
seq
sequence
dna
mutant allele
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017526770A
Other languages
English (en)
Japanese (ja)
Other versions
JP6770957B2 (ja
JP2017523810A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/GR2015/000036 external-priority patent/WO2016020710A1/en
Publication of JP2017523810A publication Critical patent/JP2017523810A/ja
Publication of JP2017523810A5 publication Critical patent/JP2017523810A5/ja
Application granted granted Critical
Publication of JP6770957B2 publication Critical patent/JP6770957B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017526770A 2014-08-07 2015-07-28 試料中のpik3ca突然変異状態を決定する方法 Active JP6770957B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462034231P 2014-08-07 2014-08-07
US62/034,231 2014-08-07
PCT/GR2015/000036 WO2016020710A1 (en) 2014-08-07 2015-07-28 Method of determining pik3ca mutational status in a sample

Publications (3)

Publication Number Publication Date
JP2017523810A JP2017523810A (ja) 2017-08-24
JP2017523810A5 true JP2017523810A5 (enExample) 2018-06-21
JP6770957B2 JP6770957B2 (ja) 2020-10-21

Family

ID=53938365

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017526770A Active JP6770957B2 (ja) 2014-08-07 2015-07-28 試料中のpik3ca突然変異状態を決定する方法

Country Status (18)

Country Link
US (1) US11279979B2 (enExample)
EP (1) EP3198026B1 (enExample)
JP (1) JP6770957B2 (enExample)
CN (1) CN106715723B (enExample)
CA (1) CA2957396C (enExample)
CY (1) CY1122647T1 (enExample)
DK (1) DK3198026T3 (enExample)
ES (1) ES2764423T3 (enExample)
HR (1) HRP20192353T1 (enExample)
HU (1) HUE047958T2 (enExample)
IL (1) IL250392B (enExample)
LT (1) LT3198026T (enExample)
PL (1) PL3198026T3 (enExample)
PT (1) PT3198026T (enExample)
RS (1) RS59710B1 (enExample)
SI (1) SI3198026T1 (enExample)
SM (1) SMT202000005T1 (enExample)
WO (1) WO2016020710A1 (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE049886T2 (hu) 2010-05-14 2020-10-28 Massachusetts Gen Hospital Tumorspecifikus neoantigéneket tartalmazó készítmények, tumorok kezelésében történõ alkalmazásra
WO2015039024A1 (en) 2013-09-16 2015-03-19 Oregon Health & Science University Bioabsorbable clips and applicator for tissue closure
WO2015077717A1 (en) 2013-11-25 2015-05-28 The Broad Institute Inc. Compositions and methods for diagnosing, evaluating and treating cancer by means of the dna methylation status
WO2015085147A1 (en) 2013-12-05 2015-06-11 The Broad Institute Inc. Polymorphic gene typing and somatic change detection using sequencing data
BR112016014410A2 (pt) 2013-12-20 2018-02-20 The Broad Institute Inc. terapia de combinação com vacina de neoantígeno
CN107106182B (zh) 2014-11-03 2019-11-22 俄勒冈健康与科学大学 用于组织闭合的夹具和施用器
EP3234130B1 (en) 2014-12-19 2020-11-25 The Broad Institute, Inc. Methods for profiling the t-cell- receptor repertoire
EP3234193B1 (en) 2014-12-19 2020-07-15 Massachusetts Institute of Technology Molecular biomarkers for cancer immunotherapy
BR112017024797A2 (pt) 2015-05-20 2018-08-07 The Broad Institute Inc. neoantígenos partilhados
EP3358020B1 (en) * 2017-01-05 2021-05-19 Biodesix, Inc. Diagnostic test system for specific, sensitive and reproducible detection of circulating nucleic acids in whole blood
US11549149B2 (en) 2017-01-24 2023-01-10 The Broad Institute, Inc. Compositions and methods for detecting a mutant variant of a polynucleotide
CN118370809A (zh) 2017-04-03 2024-07-23 百欧恩泰美国公司 蛋白质抗原及其用途
CN107287309A (zh) * 2017-07-06 2017-10-24 罗保君 一种血液循环肿瘤dna点突变检测方法
KR102662580B1 (ko) * 2017-07-26 2024-05-03 세키스이 메디칼 가부시키가이샤 변이 유전자 검출 방법
CN109295175A (zh) * 2017-09-08 2019-02-01 广州健天基因技术有限公司 用于检测人胃肠道间质瘤c-kit基因v559a突变的引物、检测方法及试剂盒
CN109306374A (zh) * 2017-09-08 2019-02-05 广州健天基因技术有限公司 用于检测人类pik3ca基因e545k突变的引物、检测方法及试剂盒
JP7306618B2 (ja) * 2017-09-26 2023-07-11 東ソー株式会社 がんの転移形成能に関与する因子および前記因子を用いたがん患者の予後予測方法
TW201930340A (zh) 2017-12-18 2019-08-01 美商尼恩醫療公司 新抗原及其用途
CN107937490A (zh) * 2018-01-15 2018-04-20 福建农林大学 一种非对称pcr的试纸条检测植物病原菌的方法及试剂盒
CN111684078B (zh) * 2018-02-12 2024-04-19 豪夫迈·罗氏有限公司 通过评价肿瘤遗传异质性来预测对治疗的应答的方法
BR112020025764A2 (pt) 2018-06-19 2021-05-11 Biontech Us Inc. neoantígenos e usos dos mesmos
CN109666747A (zh) * 2019-02-20 2019-04-23 天津脉络医学检验有限公司 一种引物探针组合物及其应用
US11812966B2 (en) 2020-04-24 2023-11-14 NeuraMedica Inc. Clips, appliers, and cartridges
CN113930500B (zh) * 2020-07-13 2024-11-19 铭炽生物科技(上海)有限公司 人pik3ca基因突变的数字pcr检测方法及应用
CN112951325B (zh) * 2021-02-18 2023-04-21 北京吉因加医学检验实验室有限公司 一种用于癌症检测的探针组合的设计方法及其应用
CN113063835B (zh) * 2021-03-19 2022-08-02 中山大学 一种基于元素标记-电感耦合等离子体质谱检测策略的cfDNA分析方法及其应用
US20250092445A1 (en) * 2021-08-25 2025-03-20 Manjing Genscript Biotech Co., Ltd. Primer set and gene chip method for detecting single base mutation

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2663248T3 (es) 2004-03-02 2018-04-11 The Johns Hopkins University Mutaciones del gen de PIK3CA en cánceres humanos
US9556491B2 (en) * 2007-02-26 2017-01-31 John Wayne Cancer Institute Utility of B-RAF DNA mutation in diagnosis and treatment of cancer
US8071338B2 (en) * 2007-08-08 2011-12-06 Roche Molecular Systems, Inc. Suppression of amplification using an oligonucleotide and a polymerase significantly lacking 5′-3′ nuclease activity
GB2453173A (en) * 2007-09-28 2009-04-01 Dxs Ltd Polynucleotide primers
US20100041048A1 (en) * 2008-07-31 2010-02-18 The Johns Hopkins University Circulating Mutant DNA to Assess Tumor Dynamics
CN101445832B (zh) * 2008-12-23 2011-09-14 广州益善生物技术有限公司 Pik3ca基因突变的检测探针、液相芯片及其检测方法
CN102234685B (zh) 2010-04-23 2014-08-27 益善生物技术股份有限公司 一种pik3ca基因突变检测液相芯片
US9169514B2 (en) 2010-12-03 2015-10-27 Brandeis University Detecting nucleic acid variations within populations of genomes
CN102533958A (zh) 2010-12-28 2012-07-04 苏州科贝生物技术有限公司 一种检测人pik3ca基因突变的方法和试剂盒
EP2663652B1 (en) 2011-01-11 2018-11-14 Roche Diagniostics GmbH High resolution melting analysis as a prescreening tool
WO2012131092A2 (en) * 2011-03-31 2012-10-04 Signature Diagnostics Ag Method and kits for the prediction of response/nonresponse to the treatment with an anti-egfr antibody in patients with colorectal cancer of all uicc stages
JP6404118B2 (ja) 2011-05-04 2018-10-10 バイオセプト インコーポレイティッド 核酸配列変種を検出するための方法
KR20140057343A (ko) 2011-08-18 2014-05-12 네스텍 소시에테아노님 대립형질 변이 검출을 위한 조성물 및 방법
JP2013081450A (ja) * 2011-09-27 2013-05-09 Arkray Inc 多型検出用プローブ、多型検出方法、薬効判定方法及び多型検出用試薬キット
US11261494B2 (en) * 2012-06-21 2022-03-01 The Chinese University Of Hong Kong Method of measuring a fractional concentration of tumor DNA
EP2711432A1 (en) * 2012-09-21 2014-03-26 Genomica S.A.U. Method for detection of BRAF and PI3K mutations
CN105378160B (zh) * 2013-08-12 2018-04-17 伯乐生命医学产品有限公司 具有碱基配对的寡聚体的扩增报告子

Similar Documents

Publication Publication Date Title
JP2017523810A5 (enExample)
HRP20192353T1 (hr) Metoda određivanja mutacijskog statusa pik3ca u uzorku
US12270081B2 (en) Method for quantification of PD-L1 expression
Miotke et al. High sensitivity detection and quantitation of DNA copy number and single nucleotide variants with single color droplet digital PCR
ES2577289T3 (es) Calreticulina mutante para el diagnóstico de malignidades mieloides
JP2017525371A5 (enExample)
Cabanero et al. Circulating tumour DNA in EGFR-mutant non-small-cell lung cancer
Gonzalez-Bosquet et al. Detection of somatic mutations by high-resolution DNA melting (HRM) analysis in multiple cancers
JP7085235B2 (ja) 膵がん診断キット
Jin et al. Rapid and accurate detection of KRAS mutations in colorectal cancers using the isothermal-based optical sensor for companion diagnostics
Zeng et al. Detection of PIK3CA mutations in plasma DNA of colorectal cancer patients by an ultra-sensitive PNA-mediated PCR
Tabone et al. Multigene profiling to identify alternative treatment options for glioblastoma: a pilot study
JP2016510982A5 (enExample)
JP2015500638A5 (enExample)
JP2020019738A (ja) がんの診断のためのプローブ/プライマーライブラリー
JPWO2019045016A1 (ja) 高感度かつ定量的な遺伝子検査方法、プライマーセット、及び検査キット
KR20110042511A (ko) PNA 기반의 실시간 PCR 클램핑을 이용한 K-ras 돌연변이 검출 방법 및 키트
KR102600344B1 (ko) Kras 유전자 돌연변이 검출용 조성물 및 이를 포함하는 키트
Feuillie et al. Detection of DNA sequences refractory to PCR amplification using a biophysical SERRS assay (Surface Enhanced Resonant Raman Spectroscopy)
US12391985B2 (en) Method of determining PIK3CA mutational status in a sample
JP2014535050A5 (enExample)
RU2440415C1 (ru) Набор синтетических олигонуклеотидов для определения нуклеотидной последовательности кодирующей части гена brca1 и выявления мутаций, ассоциированных с наследственными формами рака молочной железы
WO2014078571A1 (en) Methods of detecting 14q32 translocations
JP6346493B2 (ja) ペプチドワクチン療法の効果予測方法
KR101598327B1 (ko) Dna 복제수 변이를 이용한 강직성 척추염 발병 위험도 예측용 조성물 및 이를 이용한 예측 방법